July 26, 2019
- Bhang CBD Products Now Available In Cannabis Now’s Flagship Beverly Hills Location
- Avicanna Provides Corporate Video Update and Announces Clinical Trials for Derma-Cosmetics
- Jushi’s Subsidiary Enters Into Management Services Agreement With Established Nevada Operator And Receives Key Approval For Retail and Delivery Permit In Culver City, California
Bhang Inc. (“Bhang”) (CSE: BHNG), part of CGOC’s public portfolio, is a trusted cannabis house of brands with an extensive, award-winning portfolio of over 100 cannabis, hemp-derived cannabidiol (CBD) and terpene products.
July 22, 2019 – Bhang announced that its full line of award-winning hemp-derived CBD products are now available at the Cannabis Now flagship store in Beverly Hills, California.
Avicanna Inc. (“Avicanna”) (TSX: AVCN), part of CGOC’s public portfolio, is a company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products.
July 22, 2019 – Avicanna recently commenced trading on the Toronto Stock Exchange under the symbol “AVCN”. Subsequent to that, Avicanna released a corporate video to introduce some of their team members and discuss their upcoming plans.
To view the video, please follow this link.
July 24, 2019 – Avicanna recently announced the commencement of phase I clinical trials on three of its derma-cosmetic products. Centro de Atención e Investigación Médica CAIMED S.A.S. has commenced clinical studies on Avicanna’s Pura Earth™ derma-cosmetics products in order to demonstrate their effectiveness with specific cosmetic endpoints, such as reduction of fine lines associated with aging, efficacy as a moisturizer for eczema prone skin, and reduction of sebum and redness attributed to acne.
Jushi Inc. (“Jushi”) (NEO: JUSH.B), part of CGOC’s public portfolio, is a globally-focused, multi-state cannabis and hemp operator.
July 25, 2019 – Jushi recently announced that its subsidiary, Production Excellence, LLC has received local City of North Las Vegas authorization to enter the greater Las Vegas, Nevada market under a management services agreement with Franklin Bioscience NV, LLC. Pursuant to the transaction, Jushi has also completed the purchase of the real estate associated with Franklin Bioscience Nevada’s facility in North Las Vegas, Nevada.
To read the full release please follow this link.
July 26, 2019 – Jushi announced that its subsidiary was approved as one of three applicants to move forward in the merit-based application process for a storefront retail (and ancillary delivery) permit in Culver City, California, one of the largest cannabis markets in the world. Jushi plans to build the cannabis dispensary at a prime retail location at the corner of Venice and Sepulveda Boulevards, near the City of Los Angeles.
Bhang’s award-winning product portfolio of over 100 cannabis and CBD products includes the most-awarded line of cannabis chocolate bars on the planet, as well as a premium collection of pre-rolls, vapes, beverages, gums, mouth sprays and Bhang-branded merchandise. From public companies to platinum recording artists and organic food companies, Bhang has mastered the art of harnessing mutually beneficial partnerships to bring safe, consistent and delicious products to the world.
Avicanna is an Ontario corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments: (i) cultivation and (ii) research and development. The Company’s business is focused on the development, manufacturing, and commercialization of key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics and extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates).
Jushi Inc. and its industry leading management team is building an integrated multi-state owner and operator of cannabis and hemp licenses across the United States. Jushi is focused on continuing to build a diverse multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic investments and by internally pursuing licenses in attractive jurisdictions. Additionally, Jushi plans to launch a global medical division based on the MEND brand. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis and hemp ecosystem.
|E-UPDATES – Sign up here to be included in our email blasts and receive timely updates
For further information please contact Cannabis Growth Opportunity Corporation: